News room B. Braun
Personalized cancer therapy: B. Braun and CeGaT found joint venture CeCaVa
Melsungen/Tübingen – The medical technology and pharmaceutical manufacturer B. Braun Melsungen AG and CeGaT GmbH in Tübingen have announced the creation of the joint venture CeCaVa GmbH & Co. KG.
Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day
Melsungen. Innovative ideas can come from all sorts of directions – you just have to confront them with courage and openness. This was impressively underscored by “Demo Day” on Thursday, August 30th when the results of the first round of the B. Braun Accelerators were presented.
Drug-coated Balloon SeQuent® Please Shows Positive Results in Largest Randomized Clinical Trial
Munich, August 28th: Prof. Raban Jeger from the University Hospital Basel (Switzerland) reported the late breaking results from the BASKET-SMALL 2 trial at the ESC congress in Munich, Germany.